| 6th Feb 2025 7:00 am |
RNS-R |
Novel findings using Parsortix |
| 29th Jan 2025 7:00 am |
RNS |
Analysis of CTC-DNA and ctDNA using Illumina assay |
| 24th Jan 2025 10:05 am |
RNS-R |
Parsortix used in research paper from ETH Zurich |
| 23rd Jan 2025 7:00 am |
RNS |
Trading Update |
| 26th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 23rd Sep 2024 7:00 am |
RNS |
Exclusive agreement for DNA NGS panel |
| 17th Sep 2024 7:00 am |
RNS |
Notice of Interim Results and Webcast |
| 18th Jul 2024 10:08 am |
RNS |
Standard form for notification of major holdings |
| 12th Jul 2024 3:38 pm |
RNS |
Standard form for notification of major holdings |
| 11th Jul 2024 3:07 pm |
RNS |
Result of 2024 Annual General Meeting |
| 21st Jun 2024 7:00 am |
RNS |
Result of open offer |
| 18th Jun 2024 2:41 pm |
RNS |
Posting of 2023 Annual Report & Notice of the AGM |
| 11th Jun 2024 7:00 am |
RNS |
Parsortix and assays being showcased at EACR 2024 |
| 6th Jun 2024 4:37 pm |
RNS |
Publication of Circular |
| 5th Jun 2024 4:04 pm |
RNS |
Results of placing and subscription |
| 5th Jun 2024 7:00 am |
RNS |
Proposed Placing, Subscription and Open Offer |
| 5th Jun 2024 7:00 am |
RNS |
Preliminary Results |
| 16th May 2024 7:00 am |
RNS |
Study of ovarian cancer CTCs using Parsortix |
| 3rd May 2024 7:00 am |
RNS |
New commercial agreement with large pharma |
| 24th Apr 2024 7:00 am |
RNS |
New commercial agreement with AstraZeneca |
| 22nd Apr 2024 7:00 am |
RNS |
US and EU patents for innovative CellKeep™ slide |
| 8th Apr 2024 7:00 am |
RNS |
Parsortix HER2 assay showcased at AACR 2024 |
| 22nd Mar 2024 7:00 am |
RNS |
Parsortix at European breast cancer conference |
| 22nd Jan 2024 7:00 am |
RNS |
Potential utility in precision oncology |
| 10th Jan 2024 12:57 pm |
RNS |
Standard form for notification of major holdings |
| 4th Jan 2024 7:00 am |
RNS |
Breakthrough clinical results |
| 2nd Jan 2024 7:00 am |
RNS |
Contract announcement with Eisai Inc. |
| 11th Dec 2023 7:00 am |
RNS |
Broker Announcement |
| 11th Dec 2023 7:00 am |
RNS |
Parsortix unlocks opportunities for drug discovery |
| 5th Dec 2023 7:00 am |
RNS |
ANGLE launches Portrait+ CTC kit at SABCS |
| 9th Nov 2023 7:00 am |
RNS |
Launch of PD-L1 test to support cancer studies |
| 9th Nov 2023 7:00 am |
RNS |
Trading and business update |
| 25th Oct 2023 7:00 am |
RNS |
Supporting characterisation of CTCs in HNSCC |
| 3rd Oct 2023 7:00 am |
RNS |
Parsortix outperforms standard for DTC harvest |
| 29th Sep 2023 7:00 am |
RNS |
Parsortix system showcased at ACTC conference |
| 7th Sep 2023 7:00 am |
RNS |
Interim Results for the period ended 30 June 2023 |
| 4th Sep 2023 7:00 am |
RNS |
ANGLE launch of Portrait Flex assay |
| 15th Aug 2023 7:00 am |
RNS |
ANGLE notice of interim results |
| 28th Jun 2023 4:54 pm |
RNS |
Result of 2023 Annual General Meeting |
| 27th Jun 2023 12:24 pm |
RNS |
Standard form for notification of major holdings |
